Myeloid sarcoma: an unusual presentation for acute tracheal stenosis

The Clinical Respiratory Journal
Eitan PodgaetzJames S Allan

Abstract

Extramedullary involvement of acute myelogenous leukemia (AML) is rare and has been reported under the terms myeloid sarcoma (MS), granulocytic sarcoma, chloroma, extramedullary acute myeloid leukemia, myeloblastoma and myelosarcoma. The most common extramedullary involvement includes soft tissues and lymph nodes, but it may arise in different sites of the body. There are only very few reports about MS in the pulmonary system, and involvement of the trachea is extremely rare. This is the first report of initial presentation of MS by severe acute tracheal stenosis. After failed tracheal dilatation, a tracheostomy was performed where tracheal tissue was submitted for pathology. Histology of the tracheal biopsy and bone marrow revealed AML. The patient was subsequently referred to our oncology service for further management. Myeloid sarcoma should be part of the differential for acute tracheal stenosis.

References

Feb 1, 1980·Chest·C F Winkler, R Corpus
Jan 2, 2008·Revue de pneumologie clinique·S MsaadH Ayedi
Feb 28, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jingjin JiangYihong Shen
Aug 19, 2009·American Journal of Clinical Pathology·Cristina CampidelliStefano A Pileri
Jul 29, 2011·Blood·Richard L BakstJoachim Yahalom

❮ Previous
Next ❯

Citations

Jun 28, 2020·Seminars in Diagnostic Pathology·Joseph D Khoury, Weina Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.